Sign in
In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major
Journal article   Open access  Peer reviewed

In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major

Hany M Yehia, Ebtesam M Al-Olayan, Manal F El-Khadragy and Dina M Metwally
International journal of environmental research and public health, Vol.14(7), p.777
01/07/2017
PMCID: PMC5551215
PMID: 28703780

Abstract

Animals Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Ciprofloxacin - pharmacology Ciprofloxacin - therapeutic use Female Gram-Negative Bacteria - drug effects Gram-Negative Bacteria - isolation & purification Gram-Negative Bacterial Infections - drug therapy Gram-Negative Bacterial Infections - etiology Gram-Negative Bacterial Infections - microbiology Gram-Positive Bacteria - drug effects Gram-Positive Bacteria - isolation & purification Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - etiology Gram-Positive Bacterial Infections - microbiology Leishmaniasis, Cutaneous - complications Leishmaniasis, Cutaneous - drug therapy Leishmaniasis, Cutaneous - microbiology Mice, Inbred BALB C Microbial Sensitivity Tests Sulfinic Acids - pharmacology Sulfinic Acids - therapeutic use Yeasts - drug effects Yeasts - isolation & purification
url
https://doi.org/10.3390/ijerph14070777View
Published (Version of record) Open

Metrics

1 Record Views

Details